COPM
PFE icon

Charter Oak Partners Management’s Pfizer PFE Stock Holding History

Charter Oak Partners Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$9.61M Hold
342,550
– – 7.24% 3
2014
Q2 		$9.65M Buy
342,550
+105,400
+44% +$3M 5.24% 6
2014
Q1 		$7.23M Buy
237,150
+131,750
+125% +$3.93M 5.2% 6
2013
Q4 		$3.06M Buy
+105,400
New +$3.07M 2.17% 18

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charter Oak Partners Management's PFE Position: Q3 2014 in Review

Charter Oak Partners Management held its Pfizer (PFE) position steady in Q3 2014 at 342,550 shares worth $9.61M. The position accounts for 7.24% of the portfolio, ranked #3.

Charter Oak Partners Management first reported a position in PFE in Q4 2013 and has held it in 4 quarters since. The position peaked at $9.65M in Q2 2014. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Charter Oak Partners Management held 342,550 shares of Pfizer worth $9.61M as of Q3 2014.
  • Charter Oak Partners Management left its Pfizer share count unchanged in Q3 2014.
  • Pfizer made up 7.24% of Charter Oak Partners Management's portfolio in Q3 2014, its #3 holding.
  • Charter Oak Partners Management first reported a position in Pfizer in Q4 2013 and has held it in 4 quarters since.
  • Charter Oak Partners Management's Pfizer position peaked at $9.65M in Q2 2014.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Charter Oak Partners Management's 13F filing for Q3 2014, filed 13 Nov 2014.